AI

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026

biotech

KTU chemists develop dual-action compounds to fight cancer

Jim Cornall - August 20, 2026

biotech

RSV antiviral drug receives FDA approval for phase II trial

Jim Cornall - August 20, 2026

biotech

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

Jim Cornall - August 19, 2026

AI

Vultures and AI as death detectors

Jim Cornall - November 25, 2024

AI

Applied AI and deeptech innovations take centre stage at Expand North Star 2024

Jim Cornall - October 28, 2024

AI

Cyngn gets patent for autonomous vehicle technology

Jim Cornall - September 11, 2024

AI

New dawn for AI-powered atomic-scale 3D imaging

Jim Cornall - September 3, 2024

AI

Healthy AI: sustainable artificial intelligence for healthcare

Jim Cornall - August 7, 2024

AI

Report shows researchers trust AI, but want transparency

Jim Cornall - July 25, 2024

AI

Watch: Lymbic AI at Hello Tomorrow

Jim Cornall - June 28, 2024

AI

What is swarm computing?

Jim Cornall - June 3, 2024

1...456 7 Page 5 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026 0

This week, we have a conversation about the Flexible Automation for Scalable Health (FLASH) programme, focused on the development of scalable cell-free DNA bioproduction...

KTU chemists develop dual-action compounds to fight cancer

biotech Jim Cornall - August 20, 2026 0

RSV antiviral drug receives FDA approval for phase II trial

biotech Jim Cornall - August 20, 2026 0

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

biotech Jim Cornall - August 19, 2026 0

Pilot project between BioCytics and LIDE Biotech

biotech Jim Cornall - August 19, 2026 0